The global platysmaplasty treatment market accounted for USD 1.20 billion in 2023 and is expected to reach at USD 2.69 billion by 2034 with a CAGR of 7.56% during the forecast period 2024-2034. The market will grow as a result of factors such as the growing emphasis on youthful appearance, increased awareness of cosmetic options, technological advancements in platysmaplasty techniques, and a growing focus on minimally invasive and non-invasive procedures.
Public knowledge of platysmaplasty and its possible advantages has grown as a result of easier access to information and media representations of cosmetic treatments. A more knowledgeable and possibly more accommodating patient pool has resulted from this. For instance, Allergan reported encouraging findings in 2022 from their clinical trial assessing the effectiveness and safety of their platysmaplasty treatment.
By gender, the female segment accounted for the highest revenue-grossing segment in the global platysmaplasty treatment market in 2023 owing to the increased emphasis on personal appearance and societal pressures to maintain youthfulness, leading to a higher demand for cosmetic procedures among women. For instance, in 2023 Merz Pharma introduced a new platysmaplasty treatment device with cutting-edge technologies to enhance patient outcomes. Additionally, the male segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing acceptance of cosmetic procedures among men, coupled with increasing awareness of options for enhancing appearance and maintaining a youthful look.
By end-user, the cosmetic surgery clinics segment accounted for the highest revenue-grossing segment in the global platysmaplasty treatment market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized services, state-of-the-art facilities, and personalized care, attracting more patients seeking cosmetic procedures like platysmaplasty. For instance, in 2022, Sientra announced that it would expand its offerings in the aesthetic surgical sector by acquiring a prominent platysmaplasty treatment technology firm.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high disposable income, advanced healthcare infrastructure, widespread adoption of cosmetic procedures, and favorable reimbursement policies, driving demand for platysmaplasty treatments. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of aesthetic procedures, rising disposable income levels, growing medical tourism industry, and expanding access to advanced cosmetic treatments, fostering demand for platysmaplasty in the region. For instance, in 2023, Candela Corporation introduced a novel platysmaplasty therapy platform that combines several energy-based modalities for the best possible outcomes.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Public knowledge of platysmaplasty and its possible advantages has grown as a result of easier access to information and media representations of cosmetic treatments. A more knowledgeable and possibly more accommodating patient pool has resulted from this. For instance, Allergan reported encouraging findings in 2022 from their clinical trial assessing the effectiveness and safety of their platysmaplasty treatment.
By gender, the female segment accounted for the highest revenue-grossing segment in the global platysmaplasty treatment market in 2023 owing to the increased emphasis on personal appearance and societal pressures to maintain youthfulness, leading to a higher demand for cosmetic procedures among women. For instance, in 2023 Merz Pharma introduced a new platysmaplasty treatment device with cutting-edge technologies to enhance patient outcomes. Additionally, the male segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing acceptance of cosmetic procedures among men, coupled with increasing awareness of options for enhancing appearance and maintaining a youthful look.
By end-user, the cosmetic surgery clinics segment accounted for the highest revenue-grossing segment in the global platysmaplasty treatment market in 2023 and is predicted to grow at the fastest CAGR during the forecast period owing to the rising demand for specialized services, state-of-the-art facilities, and personalized care, attracting more patients seeking cosmetic procedures like platysmaplasty. For instance, in 2022, Sientra announced that it would expand its offerings in the aesthetic surgical sector by acquiring a prominent platysmaplasty treatment technology firm.
North American region is anticipated to have the highest revenue share during the forecast period owing to the high disposable income, advanced healthcare infrastructure, widespread adoption of cosmetic procedures, and favorable reimbursement policies, driving demand for platysmaplasty treatments. Additionally, the Asia Pacific region is predicted to grow at the fastest CAGR during the forecast period owing to the increasing awareness of aesthetic procedures, rising disposable income levels, growing medical tourism industry, and expanding access to advanced cosmetic treatments, fostering demand for platysmaplasty in the region. For instance, in 2023, Candela Corporation introduced a novel platysmaplasty therapy platform that combines several energy-based modalities for the best possible outcomes.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Gender, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Platysmaplasty Treatment Market Report 2023 - 2034
Platysmaplasty Treatment Market Analysis & Forecast by Gender 2023 - 2034 (Revenue USD Bn)
- Male
- Female
Platysmaplasty Treatment Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Cosmetic Surgery Clinics
- Hospitals
- Others
Platysmaplasty Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Platysmaplasty Treatment Market: Gender Estimates & Trend Analysis
8. Platysmaplasty Treatment Market: End-User Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Platysmaplasty Treatment Market
11. Europe Global Platysmaplasty Treatment Market
12. Asia Pacific Global Platysmaplasty Treatment Market
13. Latin America Global Platysmaplasty Treatment Market
14. MEA Global Platysmaplasty Treatment Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Allergan plc
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Sientra Inc.
- Candela Corporation
- Sinclair Pharma plc
- Cutera Inc.
- Lumenis Ltd.
- InMode Ltd.
- Alma Lasers Ltd.
- Zimmer Biomet Holdings Inc.
- Solta Medical Inc.
- Cynosure LLC
- Sciton Inc.
- BTL Industries Inc.
